MOH’s plans to provide more support for eczema welcomed by patients

MOH’s plans to provide more support for eczema welcomed by patients


SINGAPORE – Patients living with eczema welcomed the Health Ministry’s plans to study whether to include the chronic condition in a scheme that will provide them with government subsidies and allow them to tap their MediSave savings for treatment.

Health Minister Ong Ye Kung announced in Parliament on March 5 that from January 2027, the Ministry of Health (MOH) will include hyperthyroidism and hypothyroidism in the Chronic Disease Management Programme (CDMP).

This would expand CDMP to cover a total of 25 chronic conditions, including diabetes mellitus, hypertension and stroke.

MOH is studying other chronic conditions, such as eczema, for inclusion in the CDMP, and will provide an update when it is ready, with a decision expected to be made in 2026.

Once a chronic condition is included in the CDMP, patients will be able to use MediSave for outpatient chronic care costs, up to the annual withdrawal limit. Besides their own MediSave savings, they can also tap the accounts of immediate family members such as their parents, children or spouse.

Government subsidies will also be rendered through the CHAS scheme, with additional subsidies provided to Pioneer Generation or Merdeka Generation cardholders.

According to information on the National Skin Centre’s (NSC) website, eczema or dermatitis refers to inflammation of the skin and varies from person to person.

In mild cases, the skin is dry, red and itchy while in more severe cases, it may ooze, crust or bleed. It may also become infected if there are cracks or breaks in the skin barrier caused by scratching.

Atopic eczema or atopic dermatitis is the most common type. It arises from a complex interplay of factors – genetic predisposition, immune dysfunction and environmental factors, according to MOH’s Agency for Care Effectiveness (ACE) in its clinical guidelines to manage mild and moderate eczema, published on Feb 27.

Referring to a 2018 study published in the British Journal of Dermatology, ACE said atopic dermatitis affects about 13.1 per cent of people in Singapore – rates in children were at 20.6 per cent, higher than the 11.1 per cent in adults.

Assistant Professor Yew Yik Weng, an NSC senior consultant, said about half of the children grow out of the disease, based on clinical observations in many countries, though there are no good scientific explanations for this.

Eczema is a chronic condition considered to be incurable, with common triggers including heat, sweat, dust, very dry weather and even stress, Prof Yew said.

Nevertheless, eczema can be well managed and controlled, and many continue to lead their lives with minimal or infrequent symptoms, added Prof Yew, who is a member of the expert group in charge of developing the ACE clinical guidelines.

Patients interviewed by The Straits Times said they have varied responses to treatments, and that the chronic condition brings about costs that go beyond medication.



Read Full Article At Source